Blectifor (caffeine citrate)
Orphan
- Region
- 🇪🇺 EU
- Active substance
- caffeine citrate
- Company
- Viridian Pharma Ltd
- Status
- Application withdrawn
- Therapeutic area
- Bronchopulmonary Dysplasia
- Designations
- Orphan
- Application
- EMEA/H/C/004100
- Official record
- www.ema.europa.eu
Indication
Indicated in preterm neonates for the prevention of bronchopulmonary dysplasia
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Gencebok Authorised · Gennisium Pharma
Follow Blectifor
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.